Stockwatch

If you had invested ₹10,000 in Aurobindo Pharma in 2025

Worth at the close on 30 Oct 2026
₹15,251
+52.5% Gain of ₹5,251 over 12 months.
Invested
₹10,000
On
30 Oct 2025
Price then
₹1,102
Price now
₹1,681
Annualised
+52.6%
Multiple
1.53×
₹8,000₹10,000₹12,000₹14,000₹16,00020252026
Aurobindo Pharma NIFTY 50, same money same dates What you put in

Value of ₹10,000 invested on 30 Oct 2025, month by month.

Was that any good?

The same money, somewhere else

WhereWorth nowChange Against AUROPHARMA
Aurobindo Pharma ₹15,251 +52.5% —
NIFTY 50 ₹8,908 -10.9% ₹6,342 more
Fixed deposit at 6.5% ₹10,650 +6.5% ₹4,601 more

The NIFTY 50 figure is the index itself over the same dates, which like this page counts price only and no dividends — so the two are measured the same way. The fixed deposit line assumes a steady 6.5% a year for the whole period. No bank held one rate that long: Indian deposit rates ran from around 9% in 2014 to about 5.5% in 2021. Treat it as a yardstick, not a record of what a deposit actually paid.

Year by year

YearChange
2026 +42.1%
2025 -11.4%
2024 +23.1%
2023 +147.3%
2022 -40.3%
2021 -20.3%

Aurobindo Pharma on the record

All-time high
₹1,734
18 Sep 2026
52-week range
₹1,080 – ₹1,740
Deepest fall
-66.1%
03 Oct 2016 to 23 Mar 2020
Market cap
₹96,744 Cr

How this was worked out

₹10,000 at ₹1,102 a share buys 9.07 shares. Held to the close of 30 Oct 2026 at ₹1,681, those shares are worth ₹15,251. Dividends are not included, and neither are brokerage, taxes or charges — the real figure would differ on both counts.

Data covers 19 May 2016 to 30 Oct 2026 (2,588 trading days), from end-of-day NSE prices. This page is a record of what prices did. It is not advice, and nothing here is a recommendation to buy or sell — read the disclaimer.

Companies of a similar size